Eli Lilly, Novo Hit With Antitrust Suit From Drug Compounder (1)

Eli Lilly & Co. and Novo Nordisk A/S were sued Wednesday by a top compounding pharmacy that makes copycat versions of their blockbuster obesity and diabetes drugs.

The lawsuit filed by Strive Specialties Inc. alleges the two pharmaceutical giants violated antitrust laws when they discouraged providers, telehealth platforms, and patients from prescribing and accessing compounded GLP-1s.

“Eli Lilly and Novo Nordisk entered exclusive agreements with telehealth providers that barred those telehealth providers from working with compounding pharmacies, cutting off an essential channel between patients with prescriptions for personalized medicines and the pharmacies that could fill those prescriptions,” Strive said in ...